Advances in Green HPLC for Pharmaceutical Analysis: Method Development, Validation, and Sustainability Assessment

Pharmaceutical analytical chemistry has a dual responsibility: it must generate scientifically defensible measurements and support a manufacturing system that is safe, efficient and increasingly sustainable. HPLC occupies a central position because of its selectivity, reproducibility, broad applicability and compatibility with ultraviolet, fluorescence, mass-spectrometric and other detectors. It is routinely applied to assay active pharmaceutical ingredients (APIs), quantify related substances and degradation products, support dissolution testing, characterize formulations, and investigate stability. The analytical laboratory, however, can consume large quantities of solvents and disposable materials relative to the amount of analyte ultimately measured.

The sustainability challenge is particularly important for reversed-phase HPLC, where acetonitrile and methanol are commonly used as organic modifiers and where conventional analytical methods may operate at millilitre-per-minute flow rates for many minutes. A single sequence containing hundreds of injections can therefore generate litres of mobile-phase waste. In addition to solvent volume, the environmental profile depends on solvent toxicity, volatility, production pathway, waste treatment, energy use, sample preparation, instrument utilization and the fate of consumables. Green analytical chemistry extends the concept of green chemistry into measurement science by emphasizing prevention of waste, reduction of hazardous substances, miniaturization, automation, direct analysis and energy efficiency.

The 12 principles of green analytical chemistry proposed by Galuszka and co-workers provide a practical framework for designing analytical methods with reduced sample and reagent requirements, fewer operations, lower waste and improved safety. These principles complement rather than replace the original principles of green chemistry.

The recent literature demonstrates that green liquid chromatography has moved beyond simple solvent substitution. Contemporary approaches integrate greener solvent systems with short columns, core-shell or sub-2-µm particles, lower flow rates, reduced injection volumes, direct sample preparation, automated workflows and systematic greenness evaluation. A 2024 review of green LC for pharmaceutical analysis highlighted NEMI, Analytical Eco-Scale, GAPI, AMGS and AGREE as important tools and discussed the emerging relationship between green analytical chemistry, white analytical chemistry and circular analytical chemistry.

This review therefore focuses specifically on the pharmaceutical HPLC workflow, from analytical target definition and method development to validation and sustainability assessment. Particular attention is given to practical decisions that can be implemented in academic laboratories and pharmaceutical quality-control environments.

Figure 1: Green HPLC Method-Development Workflow Proposed for Pharmaceutical Analysis.

GREEN ANALYTICAL CHEMISTRY AND THE PHARMACEUTICAL HPLC CONTEXT

Green analytical chemistry is concerned with reducing the environmental and health burden of analytical measurements without compromising the information quality required for a scientifically valid decision. In pharmaceutical analysis, this balance is especially important because analytical methods support decisions about identity, strength, purity, stability and product release. A method that is environmentally benign but insufficiently selective or precise is not an acceptable pharmaceutical method.

Twelve principles of green analytical chemistry

The GAC principles emphasize direct measurement, minimal sample size, in-situ analysis when possible, integration of analytical operations, automation and miniaturization, avoidance of derivatization, waste prevention, renewable or safer reagents, elimination of hazardous substances, longer instrument lifetime and increased sample throughput. Their practical value is that they translate sustainability from an abstract objective into design criteria that can be considered before a method is finalized.

WHY CONVENTIONAL HPLC NEEDS SUSTAINABILITY OPTIMIZATION

The environmental burden of an HPLC method is not determined by the solvent name alone. Two methods using the same solvent can have substantially different footprints if one uses 1.0 mL/min for 20 min and the other uses 0.3 mL/min for 5 min. Likewise, a method that replaces acetonitrile with ethanol but requires very high pressure, longer retention, more injections or repeated sample extraction may not represent a net sustainability improvement.

GREEN SOLVENTS AND MOBILE-PHASE DESIGN

Solvent choice is among the most visible decisions in green HPLC. Acetonitrile provides favorable chromatographic properties and low viscosity, but its toxicity and life-cycle considerations encourage evaluation of alternatives when chromatographic performance allows. Methanol is widely used and is often effective, but it is also hazardous and can generate significant waste. Ethanol is attractive because of its comparatively favorable safety profile and availability from renewable feedstocks in some supply chains; however, its higher viscosity can increase back pressure and may require adjustments in flow rate, temperature, column dimensions or gradient design.

Other solvents such as isopropanol, ethyl acetate and selected bio-based solvents may be useful for particular separations. Their suitability must be judged using chromatographic selectivity, UV transparency, viscosity, miscibility, pressure, analyte stability and compatibility with the detector. A solvent should not be labelled 'green' solely because it is bio-derived; the entire workflow and solvent life cycle should be considered.

Figure 4: Practical Decision Pathway for Selecting a Greener Mobile-Phase Solvent.

GREEN HPLC METHOD DEVELOPMENT

Green method development should begin before the first chromatographic experiment. The analytical target profile (ATP) should define the intended measurement, matrix, analyte concentration range, required selectivity, expected impurities, detection mode and decision criteria. Sustainability objectives can then be added to the ATP, such as maximum mobile-phase volume per injection, preferred solvent class, maximum run time, target energy use and avoidance of unnecessary sample preparation.

Analytical target profile and critical method attributes

• Define the intended use: assay, impurities, dissolution, content uniformity, stability, cleaning verification or another purpose.
• Identify critical quality attributes of the measurement: resolution, accuracy, precision, sensitivity, selectivity and reporting range.
• Identify critical method parameters: organic fraction, pH, buffer concentration, column chemistry, temperature, flow rate, injection volume and gradient profile.
• Add sustainability criteria: solvent hazard, solvent volume, waste, energy demand, number of sample-preparation steps and potential for solvent recovery.
• Set system-suitability criteria before optimization so that green improvements do not become detached from analytical quality.

Column selection and miniaturization

Column dimensions are powerful sustainability levers because solvent consumption is directly related to flow rate and run duration. Short columns can reduce analysis time, while narrow-bore columns can reduce volumetric flow. Core-shell particles can provide high efficiency at lower back pressure than some fully porous sub-2-µm systems, depending on column dimensions and instrument capabilities. The choice should nevertheless be validated for resolution, robustness and pressure stability.

Flow-rate and run-time optimization

Reducing flow rate reduces solvent consumption per unit time, but an excessively low flow may broaden peaks, reduce throughput and increase total sequence time. The relevant sustainability variable is therefore not simply flow rate but solvent volume per analysis. A useful design equation is: mobile-phase volume per injection (mL) = flow rate (mL/min) × run time (min). This simple calculation should become a routine development metric.

Sample preparation

Sample preparation can dominate the footprint of an analytical workflow. Liquid-liquid extraction, repeated centrifugation, evaporation, derivatization and extensive filtration add solvents, plastics and energy consumption. Where matrix and sensitivity allow, direct dilution, dilute-and-shoot, microextraction, solid-phase microextraction, micro-solid-phase extraction and other miniaturized approaches can substantially reduce material use. The final choice must be driven by analyte recovery, matrix effects and reproducibility rather than greenness alone.

Detection strategy

PDA/UV detection can be attractive for routine pharmaceutical assays when analyte absorptivity and selectivity are sufficient. Fluorescence or MS may provide greater sensitivity and selectivity but may involve additional gases, solvents or energy demand. Detector selection should therefore be made according to the analytical objective, with the simplest adequate detection principle generally preferred.

AQbD and design of experiments

AQbD provides a structured route for reducing empirical trial-and-error. Instead of changing one variable at a time, a statistically designed experiment can model the effects of mobile-phase composition, pH, flow rate, temperature and other factors on chromatographic responses. Sustainability responses can be incorporated alongside analytical responses. For example, the optimization function can simultaneously maximize resolution and plate count, minimize tailing and run time, and minimize solvent volume.

Figure 2: Integration of Analytical Quality by Design (AQbD) with Sustainability Objectives.

VALIDATION OF GREEN HPLC METHODS

A green analytical method must satisfy the same fundamental expectations of analytical reliability as any other pharmaceutical method. ICH Q2 (R2), effective in the European Union from 14 June 2024, provides the current framework for validation of analytical procedures used for purposes such as assay, purity, impurities and other quantitative or qualitative measurements.

Validation should be proportionate to the analytical objective. ICH Q2 (R2) emphasizes selecting validation characteristics according to the purpose of the procedure, with specificity, range, accuracy and precision forming central performance characteristics for many quantitative methods.

Specificity

Specificity is especially important when green method development uses shorter columns, faster gradients or alternative solvents. A reduction in analysis time can unintentionally reduce separation between the API and degradation products. Specificity should therefore be demonstrated using appropriate blank, placebo, standard, sample and stressed or spiked samples as applicable to the method objective.

Accuracy and precision

Accuracy and precision should be demonstrated across the validated range using scientifically justified replicate levels. A greener method should not be granted relaxed acceptance criteria merely because it is environmentally preferable. Instead, the development strategy should seek equivalent or improved analytical performance with lower resource use.

Robustness

Robustness has a sustainability dimension because a method that fails under minor operating variation generates repeat injections, repeat sample preparation and additional waste. Robustness studies should therefore consider variables that are both chromatographically critical and environmentally relevant, including flow rate, organic fraction, pH, temperature and column lot where appropriate.

SUSTAINABILITY ASSESSMENT OF HPLC METHODS

Greenness assessment converts sustainability concepts into a structured comparison. No single metric captures every dimension of an analytical method, so multiple complementary tools may be needed. NEMI provides a simple pictorial screen, whereas Analytical Eco-Scale applies penalty points. GAPI evaluates the full workflow from sample collection to determination. HPLC-EAT was developed specifically to profile environmental, health and safety impacts of LC solvents. AGREE provides a 0–1 score based on the 12 GAC principles and an interpretable pictogram.

NEMI

The National Environmental Methods Index approach classifies methods using four binary criteria related to persistent, bioaccumulative or toxic chemicals, hazardous reagents, corrosive reagents and waste generation. Its simplicity is useful for rapid comparison, but it can overlook meaningful differences in solvent volume, energy use and sample-preparation intensity.

Analytical Eco-Scale

Analytical Eco-Scale begins with an ideal score of 100 and subtracts penalty points associated with reagent hazards, quantities, energy, waste and other undesirable features. Scores above 75 are commonly interpreted as excellent greenness, 50–75 as acceptable and below 50 as inadequate, although these categories should be interpreted within the context of the method and study design.

GAPI

GAPI provides a visual assessment of the entire analytical procedure. Its pentagram-style pictogram uses color zones to identify low, medium and high environmental impact at different stages. This is particularly useful for identifying whether the main sustainability problem lies in sampling, preparation, reagents or instrumental determination.

HPLC-EAT

HPLC-EAT was developed specifically for HPLC and considers environmental, health and safety issues associated with solvents. It is therefore useful when solvent selection is the main development question. The tool can complement broader metrics such as AGREE or GAPI rather than replace them.

AGREE

AGREE translates the 12 GAC principles into a unified 0–1 scale and presents the outcome as a pictogram. It considers multiple dimensions, including sample size, solvent use, energy, waste and other procedural characteristics. Its major advantage is that it provides a single interpretable score while retaining visual information about individual principles.

Figure 3: Conceptual Sustainability Profile Illustrating How a Method Can Be Evaluated Across Multiple Dimensions. the Figure Is Illustrative, Not a Numerical Assessment of a Specific Published Method.

RECENT DEVELOPMENTS AND REPRESENTATIVE LITERATURE

Recent reviews show rapid expansion of green LC applications in pharmaceutical analysis. Ahmed et al. summarized pharmaceutical green LC studies and highlighted the use of GAPI, NEMI, Eco-Scale, AMGS and AGREE, together with emerging concepts such as white analytical chemistry and circular analytical chemistry. similarly reviewed recent green LC approaches and emphasized the continued use of GAPI, NEMI, Eco-Scale, AMGS and AGREE. A 2026 review has further emphasized the combination of AQbD with green HPLC/UPLC, including solvent reduction, miniaturized sample preparation and quantitative sustainability evaluation.

INTEGRATING VALIDATION AND SUSTAINABILITY INTO A SINGLE DEVELOPMENT FRAMEWORK

The principal methodological argument of this review is that analytical quality and greenness should be optimized together. Treating greenness as a final scoring exercise can create a misleading outcome: a method may score well because it uses little solvent while failing to resolve critical impurities. Conversely, a highly robust method may be unnecessarily resource-intensive because solvent volume, run time or sample preparation were never included as development responses.

A practical integrated framework is to define two groups of responses. The first group contains analytical responses such as resolution, theoretical plates, tailing factor, retention time, peak area precision and recovery. The second group contains sustainability responses such as solvent volume per sample, hazardous-solvent fraction, number of preparation steps, waste mass or volume and approximate energy demand. Multi-response desirability or constrained optimization can then identify operating regions that meet analytical acceptance criteria while minimizing environmental burden.

PROPOSED PRACTICAL PROTOCOL FOR GREEN HPLC DEVELOPMENT IN PHARMACEUTICAL LABORATORIES

• Step 1: State the analytical purpose and required reporting decision.
• Step 2: Establish an ATP containing both performance and sustainability objectives.
• Step 3: Prefer direct analysis and minimum sample preparation whenever scientifically justified.
• Step 4: Screen water-rich mobile phases and preferable organic solvents before defaulting to conventional solvent systems.
• Step 5: Compare stationary phases and column dimensions with solvent consumption and pressure as development responses.
• Step 6: Use DoE/AQbD to study the most influential chromatographic parameters rather than relying exclusively on one-factor-at-a-time experimentation.
• Step 7: Minimize run time and flow while preserving resolution and system suitability.
• Step 8: Validate according to the intended use and current ICH Q2 (R2) principles.
• Step 9: Evaluate the finalized method using at least two complementary green metrics, preferably including a broad metric such as AGREE or GAPI and an LC-focused assessment such as HPLC-EAT.
• Step 10: Record solvent volume, waste, energy-related observations and consumables so that the method can be improved over its operational lifetime.

TEMPLATE FOR REPORTING A GREEN HPLC CASE STUDY

For publication-quality reporting, authors should provide enough information for independent sustainability assessment. The following minimum dataset is recommended: analyte and matrix; column dimensions and stationary phase; mobile-phase composition; solvent grade; flow rate; temperature; injection volume; detection wavelength or detector type; total run time; sample-preparation steps and solvent volumes; number of injections; waste volume; system-suitability criteria; validation results; and the values or inputs used for each green metric.

REGULATORY AND QUALITY-CONTROL CONSIDERATIONS

Regulatory acceptance is driven primarily by fitness for purpose, validated performance and control of the analytical procedure. Current ICH Q2 (R2) provides a harmonized validation framework, while Q14 addresses analytical procedure development and encourages a science- and risk-based approach. Green objectives should therefore be integrated into development without weakening established expectations for analytical reliability.

In pharmaceutical quality control, method transfer can also be a sustainability issue. A method that depends on a particular instrument configuration, unusually low dwell volume or specialized column may become difficult to transfer, leading to redevelopment and additional solvent consumption. Robust method design should therefore include transferability, instrument availability and lifecycle considerations.

Documentation should distinguish between a method that is validated and a method that has been shown to be greener. Validation demonstrates analytical fitness; greenness assessment characterizes sustainability. Both are needed for a credible green-HPLC claim.

CHALLENGES AND LIMITATIONS

• Green-solvent substitution can change selectivity, viscosity, pressure and detector compatibility.
• Different greenness metrics use different boundaries, assumptions and weighting schemes; scores from different tools are not directly interchangeable.
• Many studies report greenness without providing enough raw information to reproduce the assessment.
• Life-cycle impacts of solvent manufacture, transport, purification and disposal are often unavailable at laboratory level.
• Miniaturization may require specialized instruments or columns and may create a practical barrier in smaller laboratories.
• Shorter methods may increase co-elution risk and can require more sophisticated detectors.
• Solvent recovery is not automatically greener if the recovery process consumes excessive energy or produces secondary waste.
• Regulatory and compendial familiarity can slow adoption of nontraditional solvents or rapidly changing chromatographic platforms.
• Some published claims use the term 'green' without quantitative comparison to a conventional method; such claims should be interpreted cautiously.

FUTURE PERSPECTIVES

The future of sustainable pharmaceutical chromatography is likely to involve convergence rather than a single technological breakthrough. AQbD can reduce experimental burden; machine-learning and Bayesian optimization can accelerate exploration of chromatographic design spaces; miniaturized LC can reduce solvent use; automated sample preparation can reduce handling; and digital laboratory systems can capture resource-use data for continuous improvement.

White analytical chemistry provides a useful conceptual direction because it considers green, analytical-performance and practical/economic dimensions together. Circular analytical chemistry extends this further by emphasizing resource circulation, waste minimization and lifecycle thinking. Recent literature places these concepts alongside established green metrics and suggests that sustainability evaluation is moving from a single 'greenness score' toward multidimensional decision frameworks. citeturn0search0turn0search8

Figure 5: Roadmap from Conventional Chromatography Toward Circular and White Analytical Chemistry.

CONCLUSION

Green HPLC represents a transition from solvent substitution toward comprehensive redesign of pharmaceutical analytical workflows. The most effective strategies combine safer solvent selection with reduction of solvent volume, shorter analysis time, miniaturized columns, efficient stationary phases, reduced sample preparation, automation and statistically guided optimization. Importantly, environmental improvement must be achieved without compromising specificity, accuracy, precision, robustness or other requirements of the analytical purpose.

Greenness assessment tools provide complementary information rather than a universal ranking system. NEMI is useful for rapid screening; Eco-Scale offers a penalty-based quantitative view; GAPI provides a whole-workflow visual profile; HPLC-EAT focuses on LC solvent impacts; and AGREE integrates the 12 GAC principles into a unified score. The strongest reporting practice is therefore to combine at least two metrics and disclose all assumptions and raw inputs.

The integration of AQbD, ICH Q2 (R2) validation and sustainability assessment offers a practical framework for pharmaceutical laboratories. Future green HPLC methods should be designed around both analytical target profiles and sustainability targets, with continuous monitoring of solvent consumption, waste and operational efficiency. This approach can move pharmaceutical analysis toward safer, lower-waste and more resource-efficient laboratory practice while preserving the high level of analytical confidence required for medicine quality.

DECLARATIONS

Author contributions

Sandrapati Keerthana Madhuri: Conceptualization, literature review, manuscript drafting and scientific editing. Dr. M. Kishore Babu: Supervision, critical review and final approval. Ch. Maruthi Manoj, D. Newlin Preethy and Siddha Geetika: Literature collection, data organization, table preparation and manuscript review. All authors approved the final manuscript.

Funding

No specific external funding was received for preparation of this review article.

Conflict of interest

The authors declare no conflict of interest.

Data availability

No new experimental dataset was generated. Literature sources used for the review are listed in the references.

Acknowledgements

The authors acknowledge QIS College of Pharmacy, Ongole, Andhra Pradesh, India, for academic support and access to scholarly resources.

REFERENCES

1. Anastas PT, Warner JC. Green Chemistry: Theory and Practice. New York: Oxford University Press; 1998.
2. Gałuszka A, Migaszewski Z, Namieśnik J. The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices. TrAC Trends Anal Chem. 2013;50:78-84.
3. Płotka-Wasylka J. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta. 2018;181:204-209. doi:10.1016/j.talanta.2018.01.013.
4. Van Aken K, Strekalova E, Nifantiev I. Green analytical chemistry metrics: a review. Talanta. 2022;238:123046. doi:10.1016/j.talanta.2021.123046.
5. Gałuszka A, Konieczka P, Migaszewski ZM, Namieśnik J. Analytical Eco-Scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61-72. doi:10.1016/j.trac.2012.03.013.
6. Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE—Analytical GREEnness Metric Approach and Software. Anal Chem. 2020;92 (14):10076-10082. doi:10.1021/acs.analchem.0c01887.
7. Gaber Y, Törnvall U, Kumar MA, Amin MA, Hatti-Kaul R. HPLC-EAT (Environmental Assessment Tool): a tool for profiling safety, health and environmental impacts of liquid chromatography methods. Green Chem. 2011;13:2021-2029. doi:10.1039/C0GC00667J.
8. International Council for Harmonisation. ICH Q2 (R2): Validation of Analytical Procedures. Geneva: ICH; 2023.
9. European Medicines Agency. ICH Q2 (R2) Validation of analytical procedures. Effective 14 June 2024; updated 20 February 2026.
10. International Council for Harmonisation. ICH Q14: Analytical Procedure Development. Geneva: ICH; 2023.
11. Ahmed M, Abdullah, Eiman E, Al-Ahmary KM, Aftab F, Sohail A, et al. Advances in green liquid chromatography for pharmaceutical analysis: a comprehensive review on analytical greenness to sustainable chemistry approaches. Microchem J. 2024;205:111400. doi:10.1016/j.microc.2024.111400.
12. Patil SD, Karode SR, Kolate NR, Korde TM. Recent approaches in green liquid chromatography for pharmaceutical analysis: a comprehensive review on green analytical sustainable chemistry. Sustainable Chemistry One World. 2025;6:100069. doi:10.1016/j.scowo.2025.100069.
13. Kiran Kumar Byram, Patel S, Patel C, Shaik RB, Muthyam SK. Green analytical chemistry in pharmaceutical method development: sustainable approaches. Int J Pharm Drug Anal. 2026;14 (2). doi:10.47957/ijpda.v14i2.721.
14. P. Sai Teja. Green Analytical Chemistry (GAC): Metrics, Method Development, and Regulatory Acceptance. World J Pharm Sci. 2026;14 (1).
15. Archana K, Vigneshwaran G, Sumithra M. Green Analytical Chemistry and Metrics for Sustainable Pharmaceuticals: A Comprehensive Review. Curr Pharm Anal. 2026.
16. Gopaiah KV, Medarametla RT, Kumar JNS, Sahithi C, Prasanna DES, Sathwik G, et al. Comprehensive analysis of nizatidine: pharmacodynamics and pharmacokinetics in anti-ulcer treatment. World J Adv Res Rev. 2024;23 (3):2260-2266. doi:10.30574/wjarr.2024.23.3.2855.
17. Mandadapu G, Kolli P, Gopaiah KV, Medarametla RT, et al. Formulation of fenofibrate capsules by dropping method using PEG 6000 and PEG 4000 to enhance solubility. World J Biol Pharm Health Sci. 2024;19 (1):95-102. doi:10.30574/wjbphs.2024.19.1.0409.
18. Pamidi MP, Gopaiah KV. Artificial intelligence in pharmacy practice: transforming medication safety, clinical decision-making, and patient-centered care. Int J Pharm Sci. 2026;4 (9):3739-3753. doi:10.5281/zenodo.23022673.
19. Płotka-Wasylka J, Rutkowska M, Owczarek K, Tobiszewski M, Namieśnik J. Extraction with deep eutectic solvents. TrAC Trends Anal Chem. 2017;88:148-156.
20. Sheldon RA. The E factor: fifteen years on. Green Chem. 2007;9:1273-1283.
21. Tobiszewski M. Metrics for green analytical chemistry. Anal Methods. 2016;8:2993-2999.
22. Armenta S, Garrigues S, de la Guardia M. Green analytical chemistry. TrAC Trends Anal Chem. 2008;27 (6):497-511.
23. Pena-Pereira F, Kloskowski A, Namieśnik J. Perspectives on green analytical chemistry—current status, challenges and future trends. Microchem J. 2019;146:243-253.
24. Koel M. Ionic liquids in chemical analysis. Crit Rev Anal Chem. 2005;35:177-192.
25. Welch CJ, Wu N, Biba M, Hartman R, Brkovic T, Gong X, et al. Greening analytical chromatography. TrAC Trends Anal Chem. 2010;29 (7):667-680.
26. Kümmerer K. Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and sustainable pharmacy. Green Chem. 2007;9:899-907.
27. Jiménez-González C, Curzons AD, Constable DJC, Cunningham VL. Cradle-to-gate life cycle assessment of chemical processes. Int J Life Cycle Assess. 2004;9:114-121.
28. Capello C, Fischer U, Hungerbühler K. What is a green solvent? A comprehensive framework for the environmental assessment of solvents. Green Chem. 2007;9:927-934.
29. Prat D, Hayler J, Wells A, Baitz C, Bos J, Bras L, et al. CHEM21 selection guide of classical- and less classical-solvents. Green Chem. 2016;18:288-296.
30. Henderson RK, Jiménez-González C, Constable DJC, Alston SR, Inglis GGA, Fisher G, et al. Expanding GSK's solvent selection guide—embedding sustainability into solvent selection starting at medicinal chemistry. Green Chem. 2011;13:854-862.
31. Tobiszewski M, Namieśnik J. Scoring of solvents used in analytical laboratories by their environmental impact. Environ Sci Pollut Res Int. 2015;22:2724-2732.
32. Kaljurand M, Leitner NKV. Toward a greener analytical chemistry. Pure Appl Chem. 2006;78:1957-1966.
33. American Chemical Society. Principles of green chemistry. Washington, DC: ACS; accessed 2026.
34. United Nations. Transforming our world: the 2030 Agenda for Sustainable Development. New York: United Nations; 2015.
35. European Commission. European Green Deal. Brussels: European Commission; 2019.
36. Ahmed M, Abdullah, Eiman E, et al. Green liquid chromatography and pharmaceutical analysis: recent developments in solvent selection and sustainability assessment. Microchem J. 2024;205:111400.
37. International Council for Harmonisation. ICH Q9 (R1): Quality Risk Management. Geneva: ICH; 2023.
38. International Council for Harmonisation. ICH Q10: Pharmaceutical Quality System. Geneva: ICH; 2008.
39. Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. Hoboken: Wiley; 2010.
40. Dong MW. Modern HPLC for Practicing Scientists. Hoboken: Wiley; 2006.